SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011802
Filing Date
2018-08-14
Accepted
2018-08-14 16:19:52
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 625916
2 ex10-5.htm EX-10.5 16835
3 ex31-1.htm EX-31.1 12322
4 ex31-2.htm EX-31.2 12192
5 ex32-1.htm EX-32.1 9536
6 ex10-5_001.jpg GRAPHIC 24558
  Complete submission text file 0001493152-18-011802.txt   2148805

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rttr-20180630.xml EX-101.INS 210996
8 XBRL SCHEMA FILE rttr-20180630.xsd EX-101.SCH 21901
9 XBRL CALCULATION FILE rttr-20180630_cal.xml EX-101.CAL 28376
10 XBRL DEFINITION FILE rttr-20180630_def.xml EX-101.DEF 81326
11 XBRL LABEL FILE rttr-20180630_lab.xml EX-101.LAB 178633
12 XBRL PRESENTATION FILE rttr-20180630_pre.xml EX-101.PRE 139261
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 181017839
SIC: 2834 Pharmaceutical Preparations